Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × Losartan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 6 Breast Neoplasms 5 Radiation Fibrosis Syndrome 3 Lung Neoplasms 2 Glioblastoma 2 Thrombocytosis 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Peripheral Nervous System Diseases 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Standard of Care 7 Surveys and Questionnaires 6 COVID-19 Vaccines 6 Blood Specimen Collection 6 Specimen Handling 5 BNT162 Vaccine 5 2019-nCoV Vaccine mRNA-1273 4 Surgical Procedures, Operative 3 Practice Guidelines as Topic 3 Hydroxychloroquine 3 tocilizumab 2 sotrovimab 2 sinovac COVID-19 vaccine 2 cilgavimab and tixagevimab drug combination 2 Pandemic Preparedness 2 Data Collection 2 CVnCoV COVID-19 vaccine 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 selinexor 1 remdesivir 1 regorafenib 1 proxalutamide 1 palbociclib 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1 ciclesonide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04447235 2022-08-09

TITAN

Instituto do Cancer do Estado de São Paulo

Phase 2 Terminated

COVID-19, Neoplasms, Coronavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡